Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation

To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Meta-analysis comparing study effects using four summary estimates. Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Judith Prochaska, PhD, MPH, is Associate Professor in the Department of Medicine at Stanford University with the Stanford Prevention Research Center.

Publication

 

Image courtesy of the interviewee


Report Infringement

Sign-up

Leave a Reply

Your email address will not be published. Required fields are marked *

×
Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access Faculti through your on-campus or proxy IP address. Alternatively, as a Guest, you have insight(s) remaining for this month. Register for free and view more today.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×